Records 1 - 15
| Contribution of UGT1A1 genetic polymorphisms related to axitinib pharmacokinetics to safety and efficacy in patients with renal cell carcinoma.
Medical oncology (Northwood, London, England) 2018 Mar 35 (4): 51.
Igarashi Ryoma, Inoue Takamitsu, Fujiyama Nobuhiro, Tsuchiya Norihiko, Numakura Kazuyuki, Kagaya Hideaki, Saito Mitsuru, Narita Shintaro, Satoh Shigeru, Niioka Takenori, Miura Masatomo, Habuchi Tomono
| A phase I study of tivantinib in combination with temsirolimus in patients with advanced solid tumors.
Investigational new drugs 2016 Dec .
Kyriakopoulos Christos E, Braden Amy M, Kolesar Jill M, Eickhoff Jens C, Bailey Howard H, Heideman Jennifer, Liu Glenn, Wisinski Kari
| Significant change of cytochrome P450s activities in patients with hepatocellular carcinoma.
Oncotarget 2016 May .
Zhou Jun, Wen Qiang, Li Sai-Fei, Zhang Yun-Fei, Gao Na, Tian Xin, Fang Yan, Gao Jie, Cui Ming-Zhu, He Xiao-Pei, Jia Lin-Jing, Jin Han, Qiao Hai-Li
| Association of CYP2C19 *17/*17 Genotype With the Risk of Voriconazole-Associated Squamous Cell Carcinoma.
JAMA dermatology 2016 Mar .
Williams Kiyanna, Arron Sarah
| CYP2C19 Genotype Could be a Predictive Factor for Aggressive Manifestations of Hepatocellular Carcinoma Related with Chronic Hepatitis B Infection in Thailand.
Asian Pacific journal of cancer prevention : APJCP 2015 16 (8): 3253-6.
Nun-Anan Pongjarat, Chonprasertsuk Soonthorn, Siramolpiwat Sith, Tangaroonsanti Anupong, Bhanthumkomol Patommatat, Pornthisarn Bubpha, Vilaichone Ratha-Ko
| Independent and combined effects of environmental factors and CYP2C19 polymorphisms on the risk of esophageal squamous cell carcinoma in Fujian Province of China.
BMC medical genetics 2015 16 15.
Peng Xian-E, Chen Hua-Fang, Hu Zhi-Jian, Shi Xi-Sh
| Poor metabolizers at the cytochrome P450 2C19 loci is at increased risk of developing cancer in Asian populations.
PloS one 2013 8 (8): e73126.
Wang Hong, Song Kang, Chen Zenggan, Yu Yanm
| Interaction between alcohol consumption and CYP 2C19 gene polymorphism in relation to oesophageal squamous cell carcinoma.
PloS one 2012 7 (9): e43412.
Shi Yun, Luo Guo-jun, Zhang Li, Shi Ji, Zhang Dao-quan, Chen Jian-min, Chen Xiao-bo, Li Zhuo-dong, Zhao Qi
| Interaction between CYP 2C19*3 polymorphism and smoking in relation to laryngeal carcinoma in the Chinese Han population.
Genetics and molecular research : GMR 2011 10 (4): 3331-7.
Feng J, Li L, Zhao Y-S, Tang S-Q, Yang H-B, Liu S
| Interaction of drug metabolizing cytochrome P450 2D6 poor metabolizers with cytochrome P450 2C9 and 2C19 genotypes modify the susceptibility to head and neck cancer and treatment response.
Mutation research 2010 Feb 684 (1-2): 49-55.
Yadav Sunishtha S, Ruwali Munindra, Pant Mohan C, Shukla Pragya, Singh Ram L, Parmar Devend
| Association of poor metabolizers of cytochrome P450 2C19 with head and neck cancer and poor treatment response.
Mutation research 2008 Sep 644 (1-2): 31-7.
Yadav Sunishtha S, Ruwali Munindra, Shah Parag P, Mathur Neeraj, Singh Ram L, Pant Mohan C, Parmar Devend
| Implication of Xenobiotic Metabolizing Enzyme gene (CYP2E1, CYP2C19, CYP2D6, mEH and NAT2) polymorphisms in breast carcinoma.
BMC cancer 2008 8 (1): 109.
Khedhaier Achraf, Hassen Elham, Bouaouina Noureddine, Gabbouj Sallouha, Ahmed Slim Ben, Chouchane Lot
| CYP2C19 polymorphisms in patients with gastric and colorectal carcinoma.
International journal of gastrointestinal cancer 2006 37 (1): 1-5.
Tamer L, Ercan B, Ercan S, Ate? N, Ate? C, Ocal K, Dirlik M, Aydin S, Atik
| Genetic polymorphisms of cytochrome P450 in patients with hepatitis C virus-associated hepatocellular carcinoma.
Journal of gastroenterology and hepatology 2005 Aug 20 (8): 1191-7.
Mochizuki J, Murakami S, Sanjo A, Takagi I, Akizuki S, Ohnishi A
| Association of Genetic Variants of CYP2C19 and CYP2D6 with Esophageal Squamous Cell Carcinoma Risk in Northern India, Kashmir.
Nutrition and cancer 0 69 (4): 585-592.
Bhat Gulzar Ahmad, Bhat Arshid Bashir, Lone Mohd Maqbool, Dar Nazir Ahm